Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Wang, Jiao ^a   Zhang, Ru Yi ^a   Chen, Rong Ping ^a   Sun, Jia ^a   Yang, Rui ^a   Ke, Xiao Yun ^a   Chen, Hui ^a   Cai, De Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; Finnish diabetes risk score; People with high risk for diabetes; Prevalence; Risk factors

Indexed keywords

AGED; ARTICLE; BODY MASS; CHINA; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; STATISTICS; VERY ELDERLY; VULNERABLE POPULATION;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHINA; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; VULNERABLE POPULATIONS;

EID: 84879825036     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-633     Document Type: Article

References (40)

1. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. Arch Ophthalmol 2004 122 4 552 563 15078674 (Pubitemid 38456292)
2. Diabetic retinopathy and systemic vascular complications. Cheung N, Wong TY, Prog Retin Eye Res 2008 27 2 161 176 10.1016/j.preteyeres.2007.12.001 18249026
3. Retinopathy predicts coronary heart disease mortality. Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ, Heart 2008 95 5 391 394 10.1136/hrt.2008.146670 18697802
4. Prevalence of diabetes among Men and women in china. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. N Engl J Med 2010 362 12 1090 1101 10.1056/NEJMoa0908292 20335585
5. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, et al. Diab/Metab Res Reviews 2012 28 3 276 283
6. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Lee KM, Sum WM, Clin Exp Optometry 2011 94 4 371 375 10.1111/j.1444-0938.2010.00574.x
7. Obesity and its associations with hypertension and type 2 diabetes among Chinese adults age 40 years and over. He YH, Jiang GX, Yang Y, Huang HE, Li R, Li XY, et al. Nutrition 2009 25 11-12 1143 1149 19592220
8. Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. Chaiyasit K, Khovidhunkit W, Wittayalertpanya S, J Med Assoc Thai 2009 92 1 108 113 19260251
9. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. Kang JH, Kim C, Han IS, Kawada T, Yu R, FEBS Lett 2007 581 23 4389 4396 10.1016/j.febslet.2007.07.082 17719033 (Pubitemid 47368195)
10. Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Winkler G, Hídvégi T, Vándorfi G, Balogh S, Jermendy G, Med Sci Monit 2013 19 67 72 23344680
11. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE, Horm Metab Res 2007 39 9 677 682 10.1055/s-2007-985353 17846976 (Pubitemid 47492652)
12. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish diabetes risk score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. Costa B, Barrio F, Piñol JL, Cabré JJ, Mundet X, Sagarra R, et al. BMC Med 2013 11 1 45 10.1186/1741-7015-11-45 23438147
13. Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico. Garcia-Alcala H, Soto Vega E, Genestier Tamborero CN, Salinas Palma JL, Hirales Tamez O, Diab Metab Syndrome Obes Targets Therapy 2012 5 403 406
14. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Hellgren MI, Petzold M, Björkelund C, Wedel H, Jansson PA, Lindblad U, Diab Med 2012 29 12 1501 1505 10.1111/j.1464-5491.2012. 03664.x
15. Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N, Diabet Med 2010 27 4 459 465 10.1111/j.1464-5491.2010.02918.x 20536519
16. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al. Diabetes Metab 2011 37 2 144 151 10.1016/j.diabet.2010.09. 006 21144787
17. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national diabetes prevention program (FIN-D2D). Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al. Diabetes Care 2010 33 10 2146 2151 10.2337/dc10-0410 20664020
18. Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Tankova T, Chakarova N, Atanassova I, Dakovska L, Diabetes Res Clin Pract 2011 92 1 46 52 10.1016/j.diabres.2010.12.020 21242013
19. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. Wang J, Stancáková A, Kuusisto J, Laakso M, J Clin Endocrinol Metab 2010 95 8 3858 3862 10.1210/jc.2010-0012 20463095
20. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Lindström J, Tuomilehto J, Diabetes Care 2003 26 3 725 731 10.2337/diacare.26.3.725 12610029 (Pubitemid 36929335)
21. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, et al. Diabetes Care 2005 28 5 1187 1194 10.2337/diacare.28.5.1187 15855587 (Pubitemid 40616633)
22. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Ophthalmology 2008 115 11 1869 1875 10.1016/j.ophtha.2008.05.014 18584872
23. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Ophthalmology 2003 110 9 1677 1682 10.1016/S0161-6420(03)00475-5 13129861 (Pubitemid 37025422)
24. Department of Noncommunicable Disease Surveillance, Definition, diagnosis and classif ication of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus Geneva: World Health Organization 1999
25. 1999 World health organization-international society of hypertension guidelines for the management of hypertension. Guidelines subcommittee, J Hypertens 1999 17 2 151 183 10067786
26. Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V, Invest Ophthalmol Vis Sci 2005 J46 7 2328 2333 (Pubitemid 43119476)
27. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al. Diabetes Care 2003 26 6 1731 1737 10.2337/diacare.26.6.1731 12766102 (Pubitemid 36929112)
28. Prevalence and associated factors of diabetic retinopathy in rural Korea: the chungju metabolic disease cohort study. Kim JH, Kwon HS, Park YM, Lee JH, Kim MS, Yoon KH, et al. J Korean Med Sci 2011 26 8 1068 10.3346/jkms.2011.26.8. 1068 21860558
29. Management of diabetic retinopathy: a systematic review. Mohamed Q, Gillies MC, Wong TY, JAMA 2007 298 8 902 916 10.1001/jama.298.8.902 17712074 (Pubitemid 47311296)
30. Prevalence of diabetic retinopathy in the United States, 2005-2008. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. JAMA 2010 304 6 649 656 10.1001/jama.2010.1111 20699456
31. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul metropolitan city-diabetes prevention program (SMC-DPP) participants. Park CY, Park SE, Bae JC, Kim WJ, Park SW, Ha MM, et al. Brit J Ophthalmol 2011 96 2 151 155
32. Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al. Retina 2012 32 2 322 329 10.1097/IAE.0b013e31821c4252 21886023
33. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. Chen H, Zheng Z, Huang Y, Guo K, Lu J, Zhang L, et al. PLoS One 2012 7 5 36718 10.1371/journal.pone.0036718 22590593
34. The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy. Cruickshanks KJ, Ritter LL, Klein R, Moss SE, Ophthalmology 1993 100 6 862 867 8510898 (Pubitemid 23163496)
35. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC, Hong Kong Med J 2005 11 6 438 444 16340019 (Pubitemid 43109981)
36. Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study. Wang FH, Liang YB, Peng XY, Wang JJ, Zhang F, Wei WB, et al. Acta Ophthalmol 2011 89 4 336 e343 10.1111/j.1755-3768. 2010.02062.x 21371287
37. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR, Diabetologia 2006 49 8 1761 1769 10.1007/s00125-006-0297-1 16736131 (Pubitemid 44025030)
38. Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY, Arch Ophthalmol 2010 128 9 1185 1190 10.1001/archophthalmol.2010. 168 20625039
39. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Klein R, Klein BE, Moss SE, Ann Intern Med 1996 124 1 Pt 2 90 96 8554220 (Pubitemid 26011603)
40. Similarities and differences in early retinal phenotypes in hypertension and diabetes. Grosso A, Cheung N, Veglio F, Wong TY, J Hypertens 2011 29 9 1667 1675 10.1097/HJH.0b013e3283496655 21841544